BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 2527224)

  • 1. The efficacy of the combination of teicoplanin or flucloxacillin with netilmicin in the treatment of Staphylococcus aureus bacteraemia.
    Degener JE; Vogel M; Michel MF; Mutsaers MM; Hop WC
    J Antimicrob Chemother; 1989 Jun; 23(6):899-904. PubMed ID: 2527224
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Early termination of a prospective, randomized trial comparing teicoplanin and flucloxacillin for treating severe staphylococcal infections.
    Calain P; Krause KH; Vaudaux P; Auckenthaler R; Lew D; Waldvogel F; Hirschel B
    J Infect Dis; 1987 Feb; 155(2):187-91. PubMed ID: 2949024
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A clinical trial of teicoplanin compared with a combination of flucloxacillin and tobramycin as antibiotic prophylaxis for cardiac surgery: the use of a scoring method to assess the incidence of wound infection.
    Wilson AP; Grüneberg RN; Treasure T; Sturridge MF
    J Hosp Infect; 1986 Mar; 7 Suppl A():105-12. PubMed ID: 2871092
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Teicoplanin monotherapy of serious infections caused by gram-positive bacteria: a re-evaluation of patients with endocarditis or Staphylococcus aureus bacteraemia from a European open trial.
    Davey PG; Williams AH
    J Antimicrob Chemother; 1991 Apr; 27 Suppl B():43-50. PubMed ID: 1829076
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Flucloxacillin treatment of methicillin-'resistant' and sensitive staphylococcal infection.
    Kidson A; Lilly HA; Lowbury EJ
    J Antimicrob Chemother; 1979 Jul; 5(4):359-64. PubMed ID: 489489
    [No Abstract]   [Full Text] [Related]  

  • 6. Efficacy and safety of teicoplanin plus rifampicin in the treatment of bacteraemic infections caused by Staphylococcus aureus.
    Yzerman EP; Boelens HA; Vogel M; Verbrugh HA
    J Antimicrob Chemother; 1998 Aug; 42(2):233-9. PubMed ID: 9738842
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Teicoplanin compared to flucloxacillin for antibiotic treatment of neutropenic patients.
    Smith CL; Milliken S; Powles R; Da Costa F; Gore M; Benjamin S; Talbot D; Ellis L; Large J; Jameson B
    Br J Haematol; 1990 Dec; 76 Suppl 2():6-9. PubMed ID: 2149055
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In-vitro modelling of the bactericidal activity of teicoplanin versus flucloxacillin as used in surgical prophylaxis, against Staphylococcus aureus.
    Steer JA; Hill GB; Robbins MJ; Newton JC; Wilson AP
    J Antimicrob Chemother; 1997 Apr; 39(4):477-81. PubMed ID: 9145820
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Teicoplanin: a well-tolerated and easily administered alternative to vancomycin for gram-positive infections in intensive care patients.
    Charbonneau P; Harding I; Garaud JJ; Aubertin J; Brunet F; Domart Y
    Intensive Care Med; 1994 Nov; 20 Suppl 4():S35-42. PubMed ID: 7699155
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Teicoplanin versus cloxacillin, cloxacillin-gentamycin and vancomycin in the treatment of experimental endocarditis caused by methicillin-sensitive Staphylococcus aureus].
    Apellaniz G; Valdés M; Pérez R; Martín-Luengo F; García A; Soria F; Gómez J
    Enferm Infecc Microbiol Clin; 1991 Apr; 9(4):208-10. PubMed ID: 1830757
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Flucloxacillin in chronic leg ulcers. Penetration of flucloxacillin into chronic leg ulcer exudate and the effect on the bacteria.
    Stürup J; Sandberg Sørensen T; Slotsbjerg T; Hofmann B
    Acta Pathol Microbiol Immunol Scand B; 1987 Aug; 95(4):213-7. PubMed ID: 3673578
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dicloxacillin and flucloxacillin twice daily with probenecid in staphylococcal infections. A clinical and pharmakokinetic evaluation.
    Hedström SA; Kahlmeter G
    Scand J Infect Dis; 1980; 12(3):221-5. PubMed ID: 7433922
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of severe sepsis in bone marrow transplant recipients with teicoplanin in combination with beta-lactams and aminoglycosides.
    Fauser AA; Lang E; Dölken G; Bross KJ; Schmid J; Sörgel F
    Infection; 1991; 19(3):195-200. PubMed ID: 1832419
    [TBL] [Abstract][Full Text] [Related]  

  • 14. "Methicillin-resistant" Staphylococcus aureus: reassessment by controlled trial in burns unit.
    Lowbury EJ; Lilly HA; Kidson A
    Br Med J; 1977 Apr; 1(6068):1054-6. PubMed ID: 322817
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The clinical efficacy of continuous-infusion flucloxacillin in serious staphylococcal sepsis.
    Leder K; Turnidge JD; Korman TM; Grayson ML
    J Antimicrob Chemother; 1999 Jan; 43(1):113-8. PubMed ID: 10381108
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro interactions of carumonam in combination with coumermycin, teicoplanin, flucloxacillin and vancomycin.
    Machka K; Milatovic D; Braveny I
    Chemioterapia; 1987 Jun; 6(2 Suppl):117-8. PubMed ID: 2978385
    [No Abstract]   [Full Text] [Related]  

  • 17. [Efficacy of teicoplanin in 25 cases of severe infections caused by gram-positive cocci].
    Potel G; Touzé MD; Meignier M; Reynaud A; Baron D
    Pathol Biol (Paris); 1988 May; 36(5):531-5. PubMed ID: 2970058
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Clinical evaluation of flucloxacillin in the treatment of serious staphylococcal infections in children].
    Saied H; Ben Attia M
    J Int Med Res; 1986; 14(5):261-6. PubMed ID: 3770291
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The in-vivo activity of co-amoxiclav with netilmicin against experimental methicillin and gentamicin resistant Staphylococcus epidermidis infection in rabbits.
    Chavanet P; Collin F; Muggeo E; Gagelin B; Chassin P; Kosmidis V; Bernard A; Kistermann JP; Portier H
    J Antimicrob Chemother; 1993 Jan; 31(1):129-38. PubMed ID: 8444657
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A large retrospective cohort study of cefazolin compared with flucloxacillin for methicillin-susceptible Staphylococcus aureus bacteraemia.
    Davis JS; Turnidge J; Tong S
    Int J Antimicrob Agents; 2018 Aug; 52(2):297-300. PubMed ID: 29499317
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.